Tender Offer Launch and Potential Transaction Update
LONDON, July 24, 2026--NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO ANY JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT.
LONDON, July 24, 2026--NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO ANY JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT.
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / July 24, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Roblox Corporation (NYSE:RBLX) securities. If you suffered a loss on your Roblox investment and would like to explore a potential recovery under the federal securities laws, Learn about Roblox Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed against Roblox Corporation that seeks ..
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / July 24, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired ZoomInfo Technologies Inc. (NASDAQ:GTM) securities. If you suffered a loss on your ZoomInfo investment and would like to explore a potential recovery under the federal securities laws, Learn about ZoomInfo Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed against ZoomInfo Technologies Inc. ..
Powered by Muse Spark 1.1, Meta AI, can now build, plan, and follow through from start to finish. The post Meta AI Doesn’t Just Think, It Acts appeared first on Meta Newsroom.
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / July 24, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Via Transportation, Inc. (NYSE:VIA) securities. If you suffered a loss on your Via Transportation, Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about Via Transportation, Inc. Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: This lawsuit is on behalf of a ..
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / July 24, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) securities. If you suffered a loss on your Regeneron investment and would like to explore a potential recovery under the federal securities laws, Learn about Regeneron Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed against Regeneron Pharmaceuticals, Inc. ..
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / July 24, 2026 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Microvast Holdings, Inc. (NASDAQ:MVST) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Microvast securities between April 1, 2025 and March 16, 2026, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site:bgandg.com/MVST. Microvast Case Details According ..
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / July 24, 2026 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Primoris Services Corporation (NYSE:PRIM) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Primoris securities between August 5, 2025 and June 22, 2026, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site:bgandg.com/PRIM. Primoris Case Details The ..
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / July 24, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating the proposed take-private acquisition of Distribution Solutions Group, Inc. (NASDAQ:DSGR) by newly formed entities controlled by LKCM Headwater Investments, LLC to determine whether the transaction is fair to DSG's unaffiliated shareholders and whether DSG's Special Committee and Board of Directors fulfilled their fiduciary duties in approving the transaction for potentially inadequate consideration. Investors who purchased DSG and continue to hold to the present are encouraged to obtain additional information and assist the investigation by visiting the firm's site:bgandg.com/DSGR. DSG Investigation Details Under the ..
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / July 24, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Lucid Group, Inc. (NASDAQ:LCID) securities. If you suffered a loss on your Lucid Group, Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about Lucid Group, Inc. Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed ..
- NewAmsterdam Pharma y Menarini Group reciben una opinión positiva del CHMP que recomienda la autorización de comercialización de Ubeslo® (monoterapia con obicetrapib) y Evlarco® (combinación de dosis fija de obicetrapib más ezetimiba) - La opinión favorable del CHMP respalda la posible...
Brand highlights discreet STD testing, Food Sensitivity, Allergy, and Lyme Disease at home test kits as part of its mission to destigmatize sexual health ATLANTA, July 24, 2026 /PRNewswire/ -- STD Hero recently attended Naughty N'awlins in New Orleans, presenting its at home STI testing...